The Massachusetts-based company's 'hybrid closed-loop insulin pump', the Omnipod Horizon, demonstrated effective blood glucose control and safety in a 36-hour study involving 24 type 1 diabetes ...

The Global Insulin Pump Market achieved a valuation of $5.90 Billion in 2024 and is anticipated to exceed $14.49 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 8.55% during the ...

Insulet (Nasdaq:PODD) announced today that it commercially launched the Omnipod 5 automated insulin delivery (AID) system in ...

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections of insulin to their first automated pump improved users’ time in a ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with ... of thousands more people with diabetes around the world.

In this episode of Vanguards of Health Care, Sheridan sits down with BI analyst Matt Henriksson for an in-depth interview about Tandem’s Mobi pump, designed for discretion and simplicity, and the ...

--(BUSINESS WIRE)-- Insulet Corporation (PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology ... for Treatment of Type 1 Diabetes (RADIANT).